Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NetraMark Holdings ( (TSE:AIAI) ) just unveiled an announcement.
NetraMark Holdings Inc. will voluntarily delist its common shares from the Canadian Securities Exchange on February 17, 2026, and begin trading on the Toronto Stock Exchange on February 18 under its existing symbol AIAI, while maintaining listings on the OTCQB and Frankfurt exchanges. The move keeps the company a reporting issuer in Canada and requires no action from shareholders.
Management positions the TSX uplisting as a key milestone that underscores NetraMark’s operational progress and is expected to strengthen its visibility and positioning in the capital markets. By aligning its AI-powered NetraAI platform with a senior exchange listing, the company aims to deepen engagement with institutional investors and pharmaceutical stakeholders as it pursues broader commercial adoption of its clinical trial analytics technology.
More about NetraMark Holdings
NetraMark Holdings Inc. is a healthcare technology company specializing in AI-driven clinical trial optimization and precision patient stratification for the pharmaceutical industry. Its core platform, NetraAI, leverages generative AI and machine learning with topology-based algorithms to segment small patient datasets, identify disease subtypes, and classify patients by drug sensitivity and treatment efficacy.
Average Trading Volume: 55,906
Technical Sentiment Signal: Hold
Current Market Cap: C$91.81M
See more insights into AIAI stock on TipRanks’ Stock Analysis page.